Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vermed management buy-out gives CardioDynamics ICG (impedance cardiography) focus:

This article was originally published in Clinica

Executive Summary

CardioDynamics (San Diego, California) has agreed to sell its disposable electrode subsidiary Vermed to the latter's management team for $8m in cash. The deal, which is expected to close in the fiscal third quarter ending August 31 2007, will enable CardioDynamics to focus on its proprietary impedance cardiography (ICG) business, which it believes holds higher growth potential. Subsequent to the sale, Vermed will supply CardioDynamics with the latter's ICG sensors under a five-year fixed price supplier agreement. Vermed houses 85 employees at its operating facilities in Bellows Fall, Vermont.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049021

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel